3D bioprinting holds incredible potential for advancing healthcare, from growing tissues for research to engineering complex organs for transplants. However, current bioprinting techniques face significant challenges, particularly high costs and slow printing speeds. These obstacles limit the accessibility and scalability of bioprinting technology, making it difficult to produce the high-quality biological models and tissues needed to address real-world clinical challenges.

​

I am developing new 3D bioprinting techniques specifically designed to overcome these limitations, tailoring them to facilitate interactions between biomimetic silicone robots and 3D bioprinted tissues across diverse applications.